{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T03:24:28Z","timestamp":1786937068841,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2026,9,5]]},"DOI":"10.1038\/s41416-026-03485-z","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T20:48:03Z","timestamp":1781297283000},"page":"747-755","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Adjuvant radiotherapy and skin cancer risk in breast cancer survivors: a nationwide cohort study in Korea"],"prefix":"10.1038","volume":"135","author":[{"given":"Je Hyun","family":"Chin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dooreh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Sun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9916-1917","authenticated-orcid":false,"given":"Soyoung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5352-8093","authenticated-orcid":false,"given":"Young Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Youn","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo-Chan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Ho","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7273-8886","authenticated-orcid":false,"given":"Chang Ik","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"3485_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1056\/NEJM198503143121101","volume":"312","author":"B Fisher","year":"1985","unstructured":"Fisher B, Bauer M, Margolese R, Poisson R, Pilch Y, Redmond C, et al. Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med. 1985;312:665\u201373.","journal-title":"N Engl J Med"},{"key":"3485_CR2","unstructured":"van Dongen JA, Bartelink H, Fentiman IS, Lerut T, Mignolet F, Olthuis G, et al. Randomized clinical trial to assess the value of breast-conserving therapy in stage I and II breast cancer, EORTC 10801 trial. J Natl Cancer Inst Monogr. 1992;11:15\u201318."},{"key":"3485_CR3","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199306033282201","volume":"328","author":"B Fisher","year":"1993","unstructured":"Fisher B, Costantino J, Redmond C, Fisher E, Margolese R, Dimitrov N, et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 1993;328:1581\u20136.","journal-title":"N Engl J Med"},{"key":"3485_CR4","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/S1470-2045(12)70042-6","volume":"13","author":"S Litiere","year":"2012","unstructured":"Litiere S, Werutsky G, Fentiman IS, Rutgers E, Christiaens MR, Van Limbergen E, et al. Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial. Lancet Oncol. 2012;13:412\u20139.","journal-title":"Lancet Oncol"},{"key":"3485_CR5","doi-asserted-by":"publisher","first-page":"301","DOI":"10.3390\/curroncol28010035","volume":"28","author":"W Li","year":"2021","unstructured":"Li W, Xiao H, Xu X, Zhang Y. The impact of radiotherapy on the incidence of secondary malignancies: a pan-cancer study in the US SEER cancer registries. Curr Oncol. 2021;28:301\u201316.","journal-title":"Curr Oncol"},{"key":"3485_CR6","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/S0140-6736(24)02319-5","volume":"405","author":"II Verginadis","year":"2025","unstructured":"Verginadis II, Citrin DE, Ky B, Feigenberg SJ, Georgakilas AG, Hill-Kayser CE, et al. Radiotherapy toxicities: mechanisms, management, and future directions. Lancet. 2025;405:338\u201352.","journal-title":"Lancet"},{"key":"3485_CR7","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/j.ijrobp.2020.03.049","volume":"107","author":"J Arsenault","year":"2020","unstructured":"Arsenault J, Parpia S, Goldberg M, Rakovitch E, Reiter H, Doherty M, et al. Acute toxicity and quality of life of hypofractionated radiation therapy for breast cancer. Int J Radiat Oncol Biol Phys. 2020;107:943\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3485_CR8","first-page":"1007","volume":"136","author":"MD Lichter","year":"2000","unstructured":"Lichter MD, Karagas MR, Mott LA, Spencer SK, Stukel TA, Greenberg ER. Therapeutic ionizing radiation and the incidence of basal cell carcinoma and squamous cell carcinoma. N Hamps Ski Cancer Study Group Arch Dermatol. 2000;136:1007\u201311.","journal-title":"N Hamps Ski Cancer Study Group Arch Dermatol"},{"key":"3485_CR9","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.breast.2017.07.004","volume":"35","author":"LM Burt","year":"2017","unstructured":"Burt LM, Ying J, Poppe MM, Suneja G, Gaffney DK. Risk of secondary malignancies after radiation therapy for breast cancer: comprehensive results. Breast. 2017;35:122\u20139.","journal-title":"Breast"},{"key":"3485_CR10","doi-asserted-by":"publisher","first-page":"e241632","DOI":"10.1001\/jamanetworkopen.2024.1632","volume":"7","author":"SJ Rezaei","year":"2024","unstructured":"Rezaei SJ, Eid E, Tang JY, Kurian AW, Kwong BY, Linos E. Incidence of nonkeratinocyte skin cancer after breast cancer radiation therapy. JAMA Netw Open. 2024;7:e241632.","journal-title":"JAMA Netw Open"},{"key":"3485_CR11","doi-asserted-by":"publisher","first-page":"959","DOI":"10.17305\/bb.2023.10029","volume":"24","author":"T Luo","year":"2024","unstructured":"Luo T, Zhang Y, Chen T, Cai Y, Yang Z. Risk and prognosis of second cutaneous melanoma after radiotherapy for breast cancer: a population-based analysis. Biomol Biomed. 2024;24:959\u201367.","journal-title":"Biomol Biomed"},{"key":"3485_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.5021\/ad.2022.34.2.105","volume":"34","author":"K Park","year":"2022","unstructured":"Park K, Bae JM, Chung KY, Yun SJ, Seo SH, Ahn HH, et al. Incidence and prevalence of skin cancers in South Korea from 2008 to 2016: a nation-wide population based study. Ann Dermatol. 2022;34:105\u20139.","journal-title":"Ann Dermatol"},{"key":"3485_CR13","doi-asserted-by":"publisher","first-page":"937","DOI":"10.4143\/crt.2021.871","volume":"54","author":"T Kim","year":"2022","unstructured":"Kim T, Yoon S, Shin DE, Lee SC, Oh J, Lee SY, et al. Incidence and survival rates of cutaneous melanoma in South Korea using nationwide health insurance claims data. Cancer Res Treat. 2022;54:937\u201349.","journal-title":"Cancer Res Treat"},{"key":"3485_CR14","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","volume":"14","author":"JS Haviland","year":"2013","unstructured":"Haviland JS, Owen JR, Dewar JA, Agrawal RK, Barrett J, Barrett-Lee PJ, et al. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol. 2013;14:1086\u201394.","journal-title":"Lancet Oncol"},{"key":"3485_CR15","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1016\/S0140-6736(17)31145-5","volume":"390","author":"CE Coles","year":"2017","unstructured":"Coles CE, Griffin CL, Kirby AM, Titley J, Agrawal RK, Alhasso A, et al. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017;390:1048\u201360.","journal-title":"Lancet"},{"key":"3485_CR16","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/S0140-6736(20)30932-6","volume":"395","author":"A Murray Brunt","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, Sydenham MA, Alhasso A, Bloomfield DJ, et al. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020;395:1613\u201326.","journal-title":"Lancet"},{"key":"3485_CR17","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.radonc.2020.09.043","volume":"154","author":"KH Choi","year":"2021","unstructured":"Choi KH, Ahn SJ, Jeong JU, Yu M, Kim JH, Jeong BK, et al. Postoperative radiotherapy with intensity-modulated radiation therapy versus 3-dimensional conformal radiotherapy in early breast cancer: a randomized clinical trial of KROG 15-03. Radiother Oncol. 2021;154:179\u201386.","journal-title":"Radiother Oncol"},{"key":"3485_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.ijrobp.2025.02.003","volume":"122","author":"M Dzhugashvili","year":"2025","unstructured":"Dzhugashvili M, Serradilla A, Fernandez-Ibiza J, Garcia G, Malinochka KM, Torres L, et al. Ultrahypofractionation and simultaneous integrated boost in breast cancer: early side effects analysis. Int J Radiat Oncol Biol Phys. 2025;122:241\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3485_CR19","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43:1130\u20139.","journal-title":"Med Care"},{"key":"3485_CR20","unstructured":"Statistics Korea. Complete Enumeration Results of the 2015 Population and Housing Census. Daejeon: Statistics Korea; 2016."},{"key":"3485_CR21","doi-asserted-by":"crossref","unstructured":"Chun KO, Yoon K-I. MIPEX and Korea: Assessment and Lessons. OMNES: J Multicult Soc 2013;4:27\u201358.","DOI":"10.15685\/omnes.2014.01.4.2.27"},{"key":"3485_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3857\/roj.2019.00577","volume":"37","author":"SJ Huh","year":"2019","unstructured":"Huh SJ, Park W, Choi DH. Recent trends in intensity-modulated radiation therapy use in Korea. Radiat Oncol J. 2019;37:249\u201353.","journal-title":"Radiat Oncol J"},{"key":"3485_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373\u201383.","journal-title":"J Chronic Dis"},{"key":"3485_CR24","doi-asserted-by":"crossref","unstructured":"Hosseinpour Z, Anari R, Kassir M, Robati RM. Trends in melanoma prevalence and risk factors by skin reactions to sun exposure in the U.S. population (1999\u20132018). J Racial Ethn Health Disparities. 2026;13:2067\u201377.","DOI":"10.1007\/s40615-025-02399-5"},{"key":"3485_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.suc.2024.11.008","volume":"105","author":"EA Asare","year":"2025","unstructured":"Asare EA. Disparities in melanoma and other high-risk skin cancers in the United States: elders, minorities, and rural populations. Surg Clin North Am. 2025;105:543\u201354.","journal-title":"Surg Clin North Am"},{"key":"3485_CR26","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1016\/j.mayocp.2023.02.030","volume":"98","author":"NC Anand","year":"2023","unstructured":"Anand NC, Campbell EH, Baum CL, Gibson LE, Todd A, Bradt JL, et al. Association of lower extremity lymphedema and nonmelanoma skin cancers. Mayo Clin Proc. 2023;98:1653\u20139.","journal-title":"Mayo Clin Proc"},{"key":"3485_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.clindermatol.2014.04.008","volume":"32","author":"R Lee","year":"2014","unstructured":"Lee R, Saardi KM, Schwartz RA. Lymphedema-related angiogenic tumors and other malignancies. Clin Dermatol. 2014;32:616\u201320.","journal-title":"Clin Dermatol"},{"key":"3485_CR28","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1067\/mjd.2002.120909","volume":"47","author":"V Ruocco","year":"2002","unstructured":"Ruocco V, Schwartz RA, Ruocco E. Lymphedema: an immunologically vulnerable site for development of neoplasms. J Am Acad Dermatol. 2002;47:124\u20137.","journal-title":"J Am Acad Dermatol"},{"key":"3485_CR29","first-page":"951","volume":"28","author":"H Furukawa","year":"2002","unstructured":"Furukawa H, Yamamoto Y, Minakawa H, Sugihara T. Squamous cell carcinoma in chronic lymphedema: case report and review of the literature. Dermatol Surg. 2002;28:951\u20133.","journal-title":"Dermatol Surg"},{"key":"3485_CR30","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.canrad.2020.05.020","volume":"25","author":"V Verdin","year":"2021","unstructured":"Verdin V, Mattart L, Cusumano PG, De Hertogh O, De Meester C, Francart D, et al. Angiosarcoma associated with radiation therapy after treatment of breast cancer. Retrospective study on ten years. Cancer Radiother. 2021;25:114\u20138.","journal-title":"Cancer Radiother"},{"key":"3485_CR31","doi-asserted-by":"crossref","unstructured":"Zhao C, Mahajan H, Dinh P, Nahar N, Hughes TM, Ngui N. An update on radiation-induced angiosarcoma of the breast: a diagnostic and management challenge. Arch Breast Cancer. 2023;10:340\u20136.","DOI":"10.32768\/abc.2023104340-346"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03485-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03485-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T02:44:12Z","timestamp":1786934652000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-026-03485-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9,5]]}},"alternative-id":["3485"],"URL":"https:\/\/doi.org\/10.1038\/s41416-026-03485-z","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"12 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All procedures performed in this study involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The study protocol was approved by the Institutional Review Board (Local IRB number: KC22ZISI0340) of Seoul St. Mary\u2019s Hospital. The need for informed consent was waived by the IRB due to the retrospective study design.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All authors have given consent for publication.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}}]}}